INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Observational study / 2018

Genetically predicted cannabis use was linked to an increased risk of schizophrenia.

Researchers used 10 genetic variants associated with cannabis use in 32,330 individuals to perform a Mendelian randomization study assessing the risk of schizophrenia in 34,241 cases and 45,604 controls. Genetically predicted cannabis use was associated with an increased risk of schizophrenia (OR: 1.37; 95% CI: 1.09-1.67; P=0.007), which matched an observational meta-analysis estimate (OR: 1.43; 95% CI: 1.19-1.67). Accounting for tobacco exposure did not change the association (OR adjusted for smoking: 1.41; 95% CI: 1.09-1.83), and genetic markers showed no evidence of pleiotropic effects.

Shows an association, not proof of cause and effect.

Study type
Mendelian randomization study
Who was studied
34,241 schizophrenia cases and 45,604 controls of predominantly European descent
What was measured
Risk of schizophrenia

THE PAPER

Cannabis use and risk of schizophrenia: a Mendelian randomization study.

Vaucher J, Keating BJ, Lasserre AM, Gan W, Lyall DM, Ward J, Smith DJ, Pell JP, Sattar N, Paré G, Holmes MV. Mol Psychiatry, 2018.

PubMed 28115737 ↗DOI 10.1038/mp.2016.252 ↗

Brain & moodOther health

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.